Literature DB >> 8046387

Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.

J N Burroughs1, R S O'Hara, C J Smale, C Hamblin, A Walton, R Armstrong, P P Mertens.   

Abstract

Methods were developed for the purification, at high yield, of four different particle types of African horsesickness virus serotype 9 (AHSV-9). These products included virus particles purified on CsCl gradients which contain proteins apparently directly comparable to those of bluetongue virus (VP1 to VP7); virus particles purified on sucrose gradients which also contain, as a variable component, protein NS2; infectious subviral particles (ISVPs), containing chymotrypsin cleavage products of VP2; and cores, obtained by treating purified ISVPs with 1 M-MgCl2 to remove the components of the outer capsid layer (VP5 and VP2 cleavage products). Additional protein bands migrating with apparent M(r)s lower than that of VP5 were detected during SDS-PAGE analysis of virus particles. These appear to be conformational variants of VP5 and are identified as VP5' and VP5". BHK-21 cells infected with this strain of AHSV-9 produce large quantities of flat, usually hexagonal crystals of VP7, a major group antigen and core protein; these were also purified. Either 20 mg of virus particles, 20 mg of ISVPs or 10 mg of cores as well as 20 mg of VP7 crystals could be purified from approximately 8 x 10(9) infected cells. None of the preparations of particles or crystals showed any detectable contamination with BHK-21 cell proteins or antigens, as determined by SDS-PAGE or indirect ELISA. Virus particle and ISVP preparations had similar specific infectivities for BHK-21 cells (approximately 1 x 10(9) TCID50/A260 unit) but the infectivity of cores was approximately 10(5)-fold lower.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046387     DOI: 10.1099/0022-1317-75-8-1849

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Cross-linked protein crystals for vaccine delivery.

Authors:  N St Clair; B Shenoy; L D Jacob; A L Margolin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Structural insight into African horsesickness virus infection.

Authors:  Violeta Manole; Pasi Laurinmäki; Wouter Van Wyngaardt; Christiaan A Potgieter; Isabella M Wright; Gert J Venter; Alberdina A van Dijk; B Trevor Sewell; Sarah J Butcher
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Purification of infective bluetongue virus particles by immuno-affinity chromatography using anti-core antibody.

Authors:  Karam Chand; Sanchay K Biswas; Bimalendu Mondal
Journal:  Virusdisease       Date:  2016-02-04

4.  C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Authors:  J R Castón; J L Martínez-Torrecuadrada; A Maraver; E Lombardo; J F Rodríguez; J I Casal; J L Carrascosa
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.

Authors:  A K Basak; P Gouet; J Grimes; P Roy; D Stuart
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Silencing of African horse sickness virus VP7 protein expression in cultured cells by RNA interference.

Authors:  Liesel Stassen; Henk Huismans; Jacques Theron
Journal:  Virus Genes       Date:  2007-09-13       Impact factor: 2.332

7.  Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.

Authors:  Susan J Dennis; Ann E Meyers; Alan J Guthrie; Inga I Hitzeroth; Edward P Rybicki
Journal:  Plant Biotechnol J       Date:  2017-08-01       Impact factor: 9.803

Review 8.  African Horse Sickness: A Review of Current Understanding and Vaccine Development.

Authors:  Susan J Dennis; Ann E Meyers; Inga I Hitzeroth; Edward P Rybicki
Journal:  Viruses       Date:  2019-09-11       Impact factor: 5.048

Review 9.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14

Review 10.  Adaptive strategies of African horse sickness virus to facilitate vector transmission.

Authors:  Anthony Wilson; Philip Scott Mellor; Camille Szmaragd; Peter Paul Clement Mertens
Journal:  Vet Res       Date:  2008-12-19       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.